Items where Author is "Baghbanian, S. M."

Article

(2025) Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis. JAMA neurology. ISSN 2168-6157 (Electronic) 2168-6149 (Print) 2168-6149 (Linking)

(2024) Consanguineous marriage among familial multiple sclerosis subjects: A national registry-based study. Heliyon. p. 11.

(2024) Disease Activity in Pregnant and Postpartum Women with Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies. Neurology: Neuroimmunology and NeuroInflammation. ISSN 23327812 (ISSN)

(2024) Efficacy and safety of peginterferon beta-1a compared to interferon beta-1a in relapsing remitting multiple sclerosis patients: A phase 3, randomized, non-inferiority clinical trial (PEGINTEGRITY). Multiple Sclerosis and Related Disorders. p. 8. ISSN 2211-0348

(2024) Evaluating efficacy and safety of ocrelizumab biosimilar (Xacrel) compared to the originator (Ocrevus) in relapsing multiple sclerosis: a phase III, randomized, equivalency, clinical trial. Scientific Reports. p. 12. ISSN 2045-2322

(2024) Investigation of pregnancy tendency, reproductive characteristics, and disability in women with multiple sclerosis: A secondary data analysis of the national registry in Iran. Current Journal of Neurology. pp. 106-116. ISSN 2717-011X

(2024) Time interval between the onset of symptoms and diagnosis of multiple sclerosis and the influential factors: A national registry-based study. Clinical Neurology and Neurosurgery. p. 7. ISSN 0303-8467

(2024) A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic. Journal of Neurology. p. 12. ISSN 0340-5354

(2024) A national registry-based study of ethnic differences in people with multiple sclerosis in Iran. Clinical Neurology and Neurosurgery. p. 5. ISSN 0303-8467

(2023) Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal. pp. 875-883. ISSN 1352-4585

(2023) Economic and Social Standing of Individuals in Iran Diagnosed with Multiple Sclerosis. Archives of Iranian Medicine. pp. 413-418. ISSN 1029-2977

(2023) Iranian specialists' approach to surgery in patients with multiple sclerosis. Current Journal of Neurology. pp. 96-102. ISSN 2717-011X

(2023) Iranian specialists' approach to treatment escalation in multiple sclerosis patients with cognitive impairment Accepted. Current Journal of Neurology. pp. 1-7. ISSN 2717-011X

(2023) Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics. Multiple Sclerosis and Related Disorders. p. 5. ISSN 2211-0348

(2023) Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter Study. Archives of Iranian Medicine. pp. 647-653. ISSN 1029-2977

(2022) Characteristics of COVID-19 in patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. p. 103437. ISSN 2211-0356 (Electronic) 2211-0348 (Print) 2211-0348 (Linking)

(2022) Characteristics of COVID-19 in patients with multiple sclerosis. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Epidemiology of familial multiple sclerosis in Iran: a national registry-based study. BMC NEUROLOGY. ISSN 1471-2377 J9 - BMC NEUROL

(2022) Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years. Multiple Sclerosis and Related Disorders. p. 103777. ISSN 2211-0356 (Electronic) 2211-0348 (Linking)

(2022) Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Socioeconomic status of Iranian patients with multiple sclerosis in relation to disease-induced disability. Multiple Sclerosis Journal. p. 935. ISSN 1352-4585

(2022) The association between reproductive characteristics and disability in iranian female patients with multiple sclerosis: a nationwide registry based cross-sectional study. Multiple Sclerosis Journal. pp. 185-186. ISSN 1352-4585

(2021) Pregnancy outcome in patients with multiple sclerosis treated with Rituximab: A case-series study. Multiple Sclerosis and Related Disorders. ISSN 2211-0348

(2021) Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study. Caspian J Intern Med. pp. 263-274. ISSN 2008-6164 (Print) 2008-6164

(2021) YY Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study. Caspian Journal of Internal Medicine. pp. 263-274. ISSN 2008-6164

(2019) Management of seizures in patients with multiple sclerosis; an Iranian consensus. Epilepsy & Behavior. ISSN 1525-5069 (Electronic) 1525-5050 (Linking)

(2019) Multiple sclerosis national registry system in Iran: Validity and reliability of a minimum data set. Multiple Sclerosis and Related Disorders. pp. 158-161. ISSN 2211-0348

(2018) Primary progressive multiple sclerosis in Iran: A consensus recommendation for diagnosis and management. Mult Scler Relat Disord. pp. 112-120. ISSN 2211-0356 (Electronic) 2211-0348 (Linking)

(2017) Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations. Multiple Sclerosis and Related Disorders. pp. 144-151. ISSN 2211-0348